|
1) 山科章, 他. 冠動脈病変の非侵襲的診断法に関するガイドライン. Circulation J. 2009; 73 (Suppl III): 1019-114
|
|
|
|
2) Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the use of cardiac radio-nuclide imaging. Executive summary. Circulation. 2003; 108: 1404-18
|
|
|
|
|
3) 玉木長良, 他. 心臓核医学検査ガイドライン. Circulation J. 2005; 69 (Suppl IV): 1125-207
|
|
|
|
|
|
4) 玉木長良, 他. 心臓核医学検査ガイドライン(改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2010tamaki.h.pdf
|
|
|
|
|
|
5) Miller JM, Rochitte CE, Dewey M, et al. Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med. 2008; 359: 2324-36
|
|
|
|
|
|
6) Pontone G, Andreini D, Bartorelli AL, et al. Diagnostic accuracy of coronary computed tomo-graphy angiography. J Am Coll Cardiol. 2009; 54: 346-55
|
|
|
|
|
|
7) Hulten EA, Carbonaro S, Petrillo SP, et al. Prognostic value of cardiac computed tomo-graphy angiography: a systemic review and meta-analysis. J Am Coll Cardiol. 2011; 57: 1237-47
|
|
|
|
|
|
8) Berman DS, Hachamovitch R, Kiat H, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol. 1995; 26: 639-47
|
|
|
|
|
|
9) Nishimura T, Nakajima K, Kusuoka H, et al. Prognostic study of risk strafitication among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT. J-ACCESS study. Eur J Nucl Med Mol Imaging. 2008; 35: 319-28
|
|
|
|
|
|
10) Hendel RC, Cerqueira M, Douglas PS, et al. A multicenter assessment of the use of single-photon emission computed tomography myocar-dial perfusion imaging with appropriateness criteria. J Am Coll Cardiol. 2010; 55: 156-62
|
|
|
|
|
|
11) Hachamovitch R, Rozanski A, Shaw LJ, et al. Impact of ischaemic and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J. 2011; 32: 1012-24
|
|
|
|
|
|
12) Dorbala S, Hachamovitch R, Di Carli MF. Myocardial perfusion imaging and multidetector computed tomographic coronary angiography: appropriate for all patients with suspected coronary artery disease？ J Am Coll Cardiol. 2006; 48: 2515-7
|
|
|
|
|
|
13) Bengel FM, Higuchi T, Javadi MS, et al. Cardiac positron emission tomography. J Am Coll Cardiol. 2009; 54: 1-15
|
|
|
|
|
|
14) Tamaki N, Morita K, Tsukamoto E. The role of fatty acids in cardiac imaging. J Nucl Med. 2000; 41: 1525-34
|
|
|
|
|
|
15) Tamaki N, Yosinaga K. Novel iodinated tracers, MIBG and BMIPP for nuclear cardiology. J Nucl Cardiol. 2011; 18: 135-43
|
|
|
|
|
|
16) Verberne HJ, Brewster LM, Somsen GA, et al. Prognostic value of myocardial 123I-metaiodo-benzylguanidine (MIBG) parameters in patients with heart failure. Eur Heart J. 2008; 29: 1147-59
|
|
|
|
|
|
17) Kuwabara Y, Tamaki N, Nakata T, et al. Determination of the survival rate in patients with congestive heart failure stratified by 123I-MIBG imaging. A meta-analysis from the studies performed in Japan. Annals Nucl Med. 2011; 25: 101-7
|
|
|
|
|